Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

Translated title of the contribution: Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

N.S. Vermeer, S.M.J.M. Straus, A.K. Mantel-Teeuwisse, F. Domergue, A.C.G. Egberts, H.G.M. Leufkens, M.L. de Bruin

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science